Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 67
- Proje 0
- Kitap 0
- Bildiri 34
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
5
Q2
17
Q3
8
Q4
6
WoS (JCR)
Q1
1
Q2
7
Q3
13
Q4
13
TR Index
6
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
1
Ort. yüzdelik
51.3%
Üst %1 payı
0.0%
Üst %10 payı
2.9%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Asprosin, but not subfatin, associated with non-obese polycystic ovary syndrome YÖKSİS SJR Q3 JCR Q3 OpenAlex 15.2%
- 2026 Evaluation of oxidative stress parameters and serum fetuin-A levels in patients with polycystic ovary syndrome YÖKSİS JCR Q4 OpenAlex 55.7%
- 2025 Assessment of Left Ventricular Strain Echocardiography in Individuals with Hashimoto’s Thyroiditis and Its Association with Serum TIMP-1 Concentration YÖKSİS SJR Q2 JCR Q1 OpenAlex 4.3%
- 2024 The effects of SGLT-2 inhibitors on echocardiographic indices and antioxidative properties in patients with heart failure with reduced ejection fraction and diabetes mellitus YÖKSİS SJR Q2 OpenAlex 61.6%
- 2023 Thyroid Ewing sarcoma and rectal administration of levothyroxine YÖKSİS TR Index OpenAlex 21.6%
- 2022 Role of prolidase activity and oxidative stress biomarkers in unexplained infertility YÖKSİS SJR Q1 JCR Q2 OpenAlex 65.8%
- 2021 Assessment of subclinical left ventricular dysfunction with speckle-tracking echocardiography in hyperthyroid and euthyroid Graves’ disease and its correlation with serum TIMP-1 YÖKSİS SJR Q3 JCR Q4 OpenAlex 68.6%
- 2021 HASHİMOTO TİROİDİTLİ HASTALARDA ATEROSKLEROZ İLE İLİŞKİLİ PARAMETRELERİN DEĞERLENDİRİLMESİ YÖKSİS OpenAlex 2.6%
- 2021 Surrenal Kitle Saptanan Hastaların Klinik, Labaratuar ve Radyolojik Bulguları; Tek Merkez Deneyimi YÖKSİS OpenAlex 7.6%
- 2017 Auditory changes in acromegaly YÖKSİS SJR Q2 JCR Q4 OpenAlex 4.9%
- 2016 CYP gene expressions in obesity associated metabolic syndrome YÖKSİS SJR Q2 JCR Q2 OpenAlex 83.6%
- 2016 Evidence for elevated LIMK2 and CFL1 and suppressed ICAM1 EZR MAP2K2 and NOS3 gene expressions in metabolic syndrome YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.1%
- 2016 Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 72.8%
- 2016 Comparison of Papillary Thyroid Carcinoma and Papillary Microcarcinoma in Terms of Clinical Features and Prognostic Factors YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 13.2%
- 2016 High Prolidase Levels may be a Marker of Irreversible Extracellular Matrix Changes in Controlled Acromegaly Patients YÖKSİS SJR Q2 JCR Q4 OpenAlex 53.6%
- 2016 Paraoxonase and arylesterase levels in autoimmune thyroid diseases YÖKSİS SJR Q2 JCR Q3 OpenAlex 71.3%
- 2016 Can Visfatin be Considered as a Diagnostic Marker for Diabetic Nephropathy YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 2.1%
- 2015 Investigation of the role of 8 OHdG and oxidative stress in papillary thyroid carcinoma YÖKSİS SJR Q1 JCR Q2 OpenAlex 79.2%
- 2015 Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy? YÖKSİS SJR Q2 JCR Q3 OpenAlex 58.9%
- 2015 Paraoxonase and arylesterase activities in patients with papillary thyroid cancer YÖKSİS SJR Q2 JCR Q3 OpenAlex 70.4%